FIGURE

Fig. 6

ID

ZDB-FIG-230704-6

Publication

McKeown et al., 2022 - Pilot Study of Jadomycin B Pharmacokinetics and Anti-Tumoral Effects in Zebrafish Larvae and Mouse Breast Cancer Xenograft Models

Other Figures

All Figure Page

Back to All Figure Page

Fig. 6

Jadomycin B did not deplete overall T cell numbers but may impact a subset of T cells. Adult female Balb/C mice were injected with 100 000 4T1 cells into the fourth mammary fat pad on day 0, followed by jadomycin B (Jad B) treatment (12 mg/kg every 12 h) from day 6 to 15 after tumor cell implantation. On day 16, animals were euthanized for T cell immunological analysis of the primary tumor, draining lymph nodes and spleen. The frequency of CD4+ TCRβ+ T cells (A), immune-activated CD69+ CD4+ T cells (B), CD8+ TCRβ+ T cells, (C) and immune-activated CD69+ CD8+ T cells (D) in the spleen, draining lymph nodes, and primary tumors were measured. The data are shown as mean ± SEM (n = 8). *P ≤ 0.05 indicates significant difference from vehicle control by unpaired t-test.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Can. J. Physiol. Pharmacol.